Search company, investor...

Innovative Cardiovascular Solutions

emblok.com

Founded Year

2012

Stage

Debt - II | Alive

Total Raised

$22.34M

Last Raised

$650K | 1 yr ago

About Innovative Cardiovascular Solutions

Innovative Cardiovascular Solutions is a privately-held clinical stage company. The company's Emblok Embolic Protection Catheter that has been designed to be utilized in Trans Aortic Valve Replacement (TAVR) procedures as well as several other left heart interventional procedures where embolic protection would be required.

Headquarters Location

1111 Short Road

Kalamazoo, Michigan, 49008,

United States

269-599-6572

Missing: Innovative Cardiovascular Solutions's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Innovative Cardiovascular Solutions's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Innovative Cardiovascular Solutions

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Innovative Cardiovascular Solutions is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,606 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Innovative Cardiovascular Solutions Patents

Innovative Cardiovascular Solutions has filed 5 patents.

The 3 most popular patent topics include:

  • Cardiac surgery
  • Valvular heart disease
  • Vascular diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/15/2020

7/27/2021

Cardiac surgery, Vascular diseases, Valvular heart disease, Cardiology, Cardiovascular physiology

Grant

Application Date

7/15/2020

Grant Date

7/27/2021

Title

Related Topics

Cardiac surgery, Vascular diseases, Valvular heart disease, Cardiology, Cardiovascular physiology

Status

Grant

Latest Innovative Cardiovascular Solutions News

Innovative Cardiovascular Solutions Raises $8M in Series C

Dec 20, 2018

Innovative Cardiovascular Solutions, a Kalamazoo, Mich.-based clinical stage company developing the Emblok™ Embolic Protection System, completed a Series C round of financing, raising a total of $8M. The company intends to use the funds to conduct clinical trials in the U.S. and Europe as well as manufacturing and operational activities. Led by R. Kevin Plemmons, co-founder and CEO, Innovative Cardiovascular Solutions provides the Emblok system, which is designed for use in Transcatheter Aortic Valve Replacement (TAVR) and other structural heart procedures where embolic protection is required. The Emblok system is an embolic protection device designed to offer complete circumferential aortic collection while protecting the cerebral, abdominal and peripheral vasculature from liberated embolic debris. In addition, the system features an integrated 4 Fr radiopaque pigtail catheter which provides the physician constant visualization while eliminating the need for unnecessary dye injections to verify positioning. The entire system is 11 Fr and allows two devices – the embolic filter and pigtail catheter – to be deployed through a single femoral puncture site. Emblok is available for investigational use only and is not approved for sale. FinSMEs

Innovative Cardiovascular Solutions Frequently Asked Questions (FAQ)

  • When was Innovative Cardiovascular Solutions founded?

    Innovative Cardiovascular Solutions was founded in 2012.

  • Where is Innovative Cardiovascular Solutions's headquarters?

    Innovative Cardiovascular Solutions's headquarters is located at 1111 Short Road, Kalamazoo.

  • What is Innovative Cardiovascular Solutions's latest funding round?

    Innovative Cardiovascular Solutions's latest funding round is Debt - II.

  • How much did Innovative Cardiovascular Solutions raise?

    Innovative Cardiovascular Solutions raised a total of $22.34M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.